One-Two Punch Therapy for the Treatment of T-Cell Malignancies Involving p53-Dependent Cellular Senescence
T-cell malignancies are still difficult to treat due to a paucity of plans that target critical dependencies. Drug-induced cellular senescence provides a permanent cell cycle arrest during tumorigenesis and cancer development, particularly when combined with senolytics to promote apoptosis of senesc...
Main Authors: | Yingjie Qing, Hui Li, Yunzi Zhao, Po Hu, Xiangyuan Wang, Xiaoxuan Yu, Mengyuan Zhu, Hongzheng Wang, Zhanyu Wang, Qinglong Guo, Hui Hui |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2021/5529518 |
Similar Items
-
Natural HDAC‐1/8 inhibitor baicalein exerts therapeutic effect in CBF‐AML
by: Xiaoxuan Yu, et al.
Published: (2020-08-01) -
Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia
by: Yingjie Qing, et al.
Published: (2021-08-01) -
FV-429 induces autophagy blockage and lysosome-dependent cell death of T-cell malignancies via lysosomal dysregulation
by: Po Hu, et al.
Published: (2021-01-01) -
Role of p53 in the Regulation of Cellular Senescence
by: Mahmut Mijit, et al.
Published: (2020-03-01) -
Is cellular senescence involved in cystic fibrosis?
by: Valentino Bezzerri, et al.
Published: (2019-02-01)